28 Jul 2025
DD
0.91%DuPont de Nemours, Inc.
$94.23
Buy range
$113–$170
Basic Materials
Hety calculates a conservative fair-value range for around 4,400 US companies from their own filed results, then shows you where the price sits against it.
No email · no card · $29/month or $250/year for the full list
Our deepest-value opportunities
28 Jul 2025
DuPont de Nemours, Inc.
$94.23
Buy range
$113–$170
Basic Materials
28 Jul 2026one year later
DuPont de Nemours, Inc.
$140.77
150-day avg
$138.72
Basic Materials
Adjusted for the Qnity spin-off and the 1-for-3 reverse split
one name at this depth
Left card, 28 July 2025. Right card, 28 July 2026. The screener’s own output a year back, next to where each name actually closed — price only, dividends excluded, which understates every figure rather than flattering it. The right-hand card carries a price, not a fresh valuation: the value range on it is the one estimated in 2025, shown so you can see the price against it. PARA has no pair because Paramount Global was folded into Paramount Skydance during 2025 and no longer trades under that ticker. DD is on a basis adjusted for its Qnity Electronics spin-off and 1-for-3 reverse split, so both of its figures are the same unit. Nothing was chosen with hindsight: these are the screener’s own rows, KMX included, which finished the year down. Past performance is not a prediction, and none of this is advice.
01
A company whose live price sits below the intrinsic value range Hety calculates from its last ten years of filed results. Not a cheap-looking multiple, and not somebody's price target — a range you can see the workings of.
02
SEC EDGAR filings, audited statements and earnings calls. Ten years, so one flattering quarter cannot carry the number, and a conservative method rather than a growth forecast that flatters it.
03
Open the screener with no signup and no card and you get one company from each undervalued tier, in full, with every tool on it. Add an email — still free — and every exchange opens up.
Intrinsic value calculator
Every company gets an intrinsic value range calculated from ten years of its own reported results, with Graham's formula worked out alongside it. The range is deliberately conservative, and you can see every input — because a valuation you cannot check is just an opinion with a number on it.
Each row is scored against the company's own reported figure and explained in a sentence, so a fail tells you how badly and a pass tells you by how much.
Undervalued stock screener
The screener covers the NYSE and Nasdaq plus the S&P 500 and Dow 30 — around 4,400 US companies, every one valued the same way, so a name in one tier is directly comparable to a name in another. Filter by exchange or index and work down the list.
Changes since yesterday's close
After US closeTier transitions, in the shape you receive them. Tickers are withheld here — this is a marketing page, not a live list.
01
Open the screener and see which businesses trade below what they're worth — or look up any stock directly.
02
Intrinsic value, Graham's tests, ten years of numbers, the investment case, and a check on management — all in one place.
03
Save it, and get told when the price or value changes so that you can act on an opportunity
No tiers engineered to put the useful parts behind a second paywall.
Hety Pro
$29
per month
$250 / year
Save $98 — about 28% off, two months free
Free to start · no signup · no card · $29/month for the full list
By comparing the live price with an intrinsic value range calculated from the company's own filings over ten years. If the price sits below the range, it appears on the undervalued list, grouped by how far below it is. The method is the same for every company, so the comparison between two names means something.
Yes. Look up any company across the S&P 500, Dow 30, NYSE and Nasdaq and you get its intrinsic value range, Graham's intrinsic value, the ten years of figures behind both, and where the current price sits against them.
Company filings from SEC EDGAR, audited financial statements, earnings-call transcripts and live market prices. Every valuation is built from ten years of a company's own reported figures — never a forecast, never a single flattering year.
No. It means the price is below what the filed numbers imply, which is a reason to start reading, not a reason to buy. Hety is a research tool, not a registered investment adviser, and it knows nothing about your circumstances. A share price may never reach an estimated range.
The NYSE and the Nasdaq, plus the S&P 500 and the Dow 30 — around 4,400 US companies, every one valued the same way so they are directly comparable. Upcoming spin-offs are tracked too.
Click Start free and you are in — no signup, no email, no card. You get one company from each undervalued tier, openable in full with every AI tool on it. Add an email (still free, still no card) and every exchange opens up. The full undervalued list — every name, grouped by how far below value it trades — is what the $29 subscription is for.
Either. $29 a month, or $250 a year — which works out about 28% cheaper, roughly two months free. Cancel any time in one click from settings; billing runs through Stripe so your card details never touch Hety.
Look it up, see the range, and decide for yourself.
Start free — no signupNo card required · then $29/month or $250/year · cancel any time